3458 results for «30MDL多少人民币»
3458 results
No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial
04 Apr 2022
Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.
Author
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease.
25 Apr 2023
When it’s (really) tight
23 Jun 2023
A 71-year-old woman was referred for coronary angiography. She underwent SAVR for AS related to bicuspidia 6 months before, and subsequently suffered from angina and increasing dyspnea 4 months after the intervention...
Author
Author
Author
Season’s greetings from the PCR Chairman and Vice-Chairman
19 Dec 2022
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval
10 Jan 2023
Foldax appoints Gregory D. Casciaro as chief executive officer
18 Oct 2022
How to easily load equipment onto small gauge guidewire?
19 Apr 2021
Using a standard syringe is a simple and cost-effective method to facilitate the loading of cath lab equipment onto a small gauge guidewire. This method has a fast learning curve and can be readily done...
Author
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease
29 Aug 2022
Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
Foldax secures approval for TRIA Mitral Heart Valve in India
05 Jun 2025
Observing an aorto-ostial lesion using TELESCOPE® in optical coherence tomography-guided percutaneous coronary intervention
17 Mar 2020
In OCT-guided PCI, observing an aorto-ostial lesion is impossible as it requires blood clearance, and the material of the guiding catheter used is not near-infrared transparent. Using a Telescope®-guiding extension catheter, the authors successfully acquired an OCT image throughout the soft polymer tip and the relatively wide...
Enrollment completed in SAVE Trial with SELUTION SLR for treatment of AV fistulas in renal dialysis patients
14 Aug 2023
First Patient enrolled in the clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft
09 Feb 2024
The top ten impactful papers from 2025 on tricuspid intervention we almost missed
13 Jan 2026
Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.
Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.
This curated selection highlights ten impactful tricuspid...
Author
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months
28 Oct 2024
COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)
02 Jan 2021
Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability
Worldwide Emergency Medical Services to receive the Andreas Grüntzig Ethica Award at EuroPCR 2023
16 May 2023
Paris, France. At EuroPCR 2023, the interventional community paid tribute to Emergency Medical Services throughout the world for their critical role in enabling timely care. International representatives of emergency medical services received the Andreas Grüntzig Ethica Award at the opening ceremony of this year’s Course, further...
